We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cites cGMP Issues, Unapproved New Drugs at Dental Technologies
FDA Cites cGMP Issues, Unapproved New Drugs at Dental Technologies
December 6, 2011
The FDA has warned Dental Technologies for cGMP violations and for manufacturing unapproved prescription drugs, including a fluoride foam and an oral solution.